ANDA 91451, held by Ingenus Pharms LLC. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 91451 (Phentermine Hydrochloride), held by Ingenus Pharms LLC, was first approved by FDA on Sep 21, 2012, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride37.5MG · tablet;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jan 7, 2013 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 21, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters